CN Patent

CN111265531A — 治疗和预防移植物抗宿主病的方法

Assigned to Pharmacyclics LLC · Expires 2020-06-12 · 6y expired

What this patent protects

本申请涉及治疗和预防移植物抗宿主病的方法。本文描述了使用ACK抑制剂治疗和预防移植物抗宿主病的方法。该方法包括向需要其的个体施用ACK抑制剂诸如依鲁替尼(ibrutinib)用于治疗和预防移植物抗宿主病。

USPTO Abstract

本申请涉及治疗和预防移植物抗宿主病的方法。本文描述了使用ACK抑制剂治疗和预防移植物抗宿主病的方法。该方法包括向需要其的个体施用ACK抑制剂诸如依鲁替尼(ibrutinib)用于治疗和预防移植物抗宿主病。

Drugs covered by this patent

Patent Metadata

Patent number
CN111265531A
Jurisdiction
CN
Classification
—
Expires
2020-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.